John Christopher Charles

John Christopher Charles discloses dealings in Prism Medical Ltd. to SEDI. We count 4 filings; the first trade dates from 16 May 2003 and the latest from 31 August 2016.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 6 September 2016 came the latest disclosure, a transaction for €5.5M in Prism Medical Ltd. Typically, a trade is published a median of 5 days after it takes place. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.